Analysts are bullish on Teva, which is once again Israel's most valuable company, due to an improved US generics price environment and promising branded drug pipeline.
image sourced from original article at https://en.globes.co.il/en/article-can-teva-sustain-its-comeback-1001493685Original article source: https://en.globes.co.il/en/article-can-teva-sustain-its-comeback-1001493685
Source Id: 8406264863
